▴ Barnidipine is an antihypertensive drag belonging to the dihydropyridine (DHP) group of calcium antagonists. It is available in a modified-release formulation which has a gradual onset of action and is effective in a single daily oral dose of 10 to 20mg.
▴ Barnidipine has selective action against cardiovascular calcium antagonist receptors and its antihypertensive action is related to the reduction of peripheral vascular resistance secondary to its vasodilatory action.
▴ The clinical antihypertensive efficacy of barnidipine is similar to that of other DHP calcium antagonists such as nitrendipine and amlodipine, and antihypertensives belonging to other drag classes such as atenolol and enalapril.
▴ Barnidipine has been found to be as efficacious and well tolerated as hydrochlorothiazide in the management of hypertension in elderly patients.
▴ Barnidipine is generally well tolerated. As with other DHP calcium antagonists, vasodilator adverse events such as headache, flushing and peripheral oedema account for most of the adverse events reported with its use and are usually transient. Oedema is less frequent than with amlodipine and nitrendipine. Its use is not associated with reflex tachycardia.
KeywordsDiastolic Blood Pressure Enalapril Atenolol Calcium Antagonist Amlodipine
- 2.Alderman M, Arakawa K, Beilin L, et al. 1999 World Health Organization — International Society of Hypertension Guidelines for the Management of Hypertension. Blood Press 1999; 8 Suppl. 1: 9–43Google Scholar
- 8.VasextenTM monograph. Yamanouchi Europe B.VGoogle Scholar
- 12.Motomura S, Hashimoto K. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine. Jpn J Pharmacol 1990 Feb; 52: 319–30PubMedCrossRefGoogle Scholar
- 21.Smilde JG. The long-term efficacy and safety profile of barnidipine. Int J Clin Pract 2000 Nov; 114 Suppl.: 20–6Google Scholar
- 22.Imai Y, Abe K, Nishiyama A, et al. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24h, daytime, and nighttime. Barnidipine Study Group. Am J Hypertens 1997 Dec; 10 (12 Pt 1): 1415–9Google Scholar
- 23.Smilde JG, Holwerda NJ, Lustermans FAT. Impact of barnidipine on 24-hour ambulatory blood pressure in patients with mild to moderate esential hypertension. J Hypertens 2000 Jun; 18 Suppl. 2: 56Google Scholar
- 27.Otterstad JE, Ruilope LM. Treatment of hypertension in the very old. Int J Clin Pract 2000 Nov; 114 Suppl.: 10–9Google Scholar
- 28.Naber FB, Hage R, Mortelmans J. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study. Int J Clin Pract 2000 Nov; 114 Suppl.: 27–35Google Scholar